Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (85)

« Back to Publications

Child and Parent Outcomes in the 2018-2019 DEPICT (Differences in Access to Emergency Pediatric Intensive Care and Care During Transport) Study: 12-Month Follow-Up Data.

Alexander EC. et al, (2026), Pediatr Crit Care Med, 27, 166 - 175

Lessons learnt from the implementation of electronic consent (eConsent) and its use across a large portfolio of trials in a UK academic clinical trials unit.

Appelbe DE. et al, (2026), Trials, 27

Novel way of displaying Delphi responses when collecting through the REDCap data collection system.

Barber VS. et al, (2026), Trials, 27

Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study.

Little M. et al, (2025), Eur Urol Focus

The impact of pausing Bruton Tyrosine Kinase inhibitor (BTKi) therapy versus continued therapy on vaccination immune response in patients with chronic lymphocytic leukaemia: the IMPROVE RCT

Cook JA. et al, (2025), Efficacy and Mechanism Evaluation, 1 - 25

Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.

Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595

3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.

Cook JA. et al, (2025), Lancet Haematol, 12, e294 - e303

Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT

Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 1 - 42

Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)

Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 43 - 44

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial

Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 47 - 48

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

Abhishek A. et al, (2025), Efficacy and Mechanism Evaluation, 12, 45 - 46

Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.

Calvert C. et al, (2025), Trials, 26

3 week pause versus continued BTKi during vaccination (IMPROVE): a randomised, open-label, superiority trial.

Parry H. et al, (2025), BRITISH JOURNAL OF HAEMATOLOGY, 206

Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge Exchange event.

Tackney MS. et al, (2024), Trials, 25

Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project.

Black J. et al, (2024), Trials, 25

Load More

1
2
3
4
5
6